LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00033333
 51.33 27.76 5587 5117 1.0918 1.0235
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 53.04 27.76 5268 5365 0.9818 0.9952
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 53.04 27.76 6563 5365 1.2231 1.0538
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 53.04 27.76 5730 5365 1.0679 1.0174
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 53.04 27.76 5770 5365 1.0753 1.0192
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 54.74 27.76 6443 5606 1.1492 1.0366
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 54.74 27.76 6936 5606 1.2371 1.0564
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 54.74 27.76 6085 5606 1.0853 1.0215
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 54.74 27.76 6117 5606 1.0910 1.0229
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 56.45 27.76 6701 5745 1.1663 1.0404
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 56.45 27.76 7250 5745 1.2619 1.0614
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 56.45 27.76 6383 5745 1.1110 1.0275
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 56.45 27.76 6420 5745 1.1174 1.0291
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 58.15 27.76 7237 5906 1.2252 1.0532
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 58.15 27.76 7571 5906 1.2818 1.0652
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 58.15 27.76 6717 5906 1.1372 1.0335
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 58.15 27.76 6760 5906 1.1445 1.0352
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 59.85 27.76 7685 6062 1.2676 1.0620
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 59.85 27.76 7939 6062 1.3095 1.0706
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 59.85 27.76 7100 6062 1.1711 1.0411
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 59.85 27.76 7151 6062 1.1795 1.0429
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 61.56 27.76 8130 6217 1.3077 1.0699
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 61.56 27.76 8294 6217 1.3340 1.0752
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 61.56 27.76 7432 6217 1.1954 1.0462
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 61.56 27.76 7489 6217 1.2046 1.0483
MN20160318_Q01
K07